|
ButazolidinDrug - Butazolidin The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Phenylbutazone
Strength -
100MG
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
008319
Product Number -
008
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Novartis Pharmaceuticals Corp
Butazolidin
Phenylbutazone 100mg Capsule; Oral
Phenylbutazone 100mg Capsule; Oral Azolid 100mg Tablet; Oral Butazolidin 100mg Tablet; Oral Pheny-pas-tebamin 50% Powder; Oral Pheny-pas-tebamin 500mg Tablet; Oral Azolid 100mg Capsule; Oral Butazolidin 100mg Capsule; Oral Phenylbutazone 100mg Capsule; Oral Phenylbutazone 100mg Capsule; Oral NewDrugInformation |